Vincent J. Milano
2016
In 2016, Vincent J. Milano earned a total compensation of $1.4M as President and Chief Executive Officer at Idera Pharmaceuticals, a 54% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $211,680 |
---|---|
Option Awards | $573,780 |
Salary | $600,000 |
Other | $31,555 |
Total | $1,417,015 |
Milano received $600K in salary, accounting for 42% of the total pay in 2016.
Milano also received $211.7K in non-equity incentive plan, $573.8K in option awards and $31.6K in other compensation.
Rankings
In 2016, Vincent J. Milano's compensation ranked 6,537th out of 14,075 executives tracked by ExecPay. In other words, Milano earned more than 53.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,537 | 54th |
Manufacturing | 2,414 | 56th |
Chemicals And Allied Products | 786 | 59th |
Drugs | 600 | 61st |
Biological Products, Except Diagnostic Substances | 111 | 60th |
Milano's colleagues
We found six more compensation records of executives who worked with Vincent J. Milano at Idera Pharmaceuticals in 2016.
2016
Sudhir Phil
Idera Pharmaceuticals
President of Research
2016
Mark Casey
Idera Pharmaceuticals
General Counsel
2016
R Fletcher
Idera Pharmaceuticals
Senior Vice President, Business Development and Strategy
2016
Louis Arcudi
Idera Pharmaceuticals
Chief Financial Officer
2016
Joanna Horobin
Idera Pharmaceuticals
Chief Medical Officer
2016
John Kirby
Idera Pharmaceuticals